{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:55:57Z","timestamp":1783641357635,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Anhui Provincial Health Research Project","award":["AHWJ2023A10095"],"award-info":[{"award-number":["AHWJ2023A10095"]}]},{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["2023AH040079"],"award-info":[{"award-number":["2023AH040079"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-025-00812-x","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:56:19Z","timestamp":1764701779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of anticoagulant therapy in patients with sepsis: a meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"24","author":[{"given":"Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaYu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenHao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"812_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"812_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392:75\u201387. https:\/\/doi.org\/10.1016\/s0140-6736(18)30696-2.","journal-title":"Lancet"},{"key":"812_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/s0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, et al. Global, regional, and National sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;395:200\u201311. https:\/\/doi.org\/10.1016\/s0140-6736(19)32989-7.","journal-title":"Lancet"},{"key":"812_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","volume":"377","author":"K Reinhart","year":"2017","unstructured":"Reinhart K, et al. Recognizing sepsis as a global health Priority - A WHO resolution. N Engl J Med. 2017;377:414\u20137. https:\/\/doi.org\/10.1056\/NEJMp1707170.","journal-title":"N Engl J Med"},{"key":"812_CR5","doi-asserted-by":"publisher","first-page":"754348","DOI":"10.3389\/fpubh.2021.754348","volume":"9","author":"D Wang","year":"2021","unstructured":"Wang D, et al. A machine learning model for accurate prediction of sepsis in ICU patients. Front Public Health. 2021;9:754348. https:\/\/doi.org\/10.3389\/fpubh.2021.754348.","journal-title":"Front Public Health"},{"key":"812_CR6","doi-asserted-by":"publisher","first-page":"e017046","DOI":"10.1136\/bmjopen-2017-017046","volume":"7","author":"T Iba","year":"2017","unstructured":"Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7:e017046. https:\/\/doi.org\/10.1136\/bmjopen-2017-017046.","journal-title":"BMJ Open"},{"key":"812_CR7","doi-asserted-by":"publisher","unstructured":"Iba T, Levy JH, Raj A, Warkentin TE. Advance in the management of Sepsis-Induced coagulopathy and disseminated intravascular coagulation. J Clin Med. 2019;8. https:\/\/doi.org\/10.3390\/jcm8050728.","DOI":"10.3390\/jcm8050728"},{"key":"812_CR8","doi-asserted-by":"publisher","first-page":"s8","DOI":"10.1177\/1076029618806424","volume":"24","author":"C Papageorgiou","year":"2018","unstructured":"Papageorgiou C, et al. Disseminated intravascular coagulation: an update on Pathogenesis, Diagnosis, and therapeutic strategies. Clin Appl Thromb Hemost. 2018;24:s8\u201328. https:\/\/doi.org\/10.1177\/1076029618806424.","journal-title":"Clin Appl Thromb Hemost"},{"key":"812_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","volume":"133","author":"SP Jackson","year":"2019","unstructured":"Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019;133:906\u201318. https:\/\/doi.org\/10.1182\/blood-2018-11-882993.","journal-title":"Blood"},{"key":"812_CR10","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/cc12783","volume":"17","author":"S Gando","year":"2013","unstructured":"Gando S, et al. A multicenter, prospective validation study of the Japanese association for acute medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care. 2013;17:R111. https:\/\/doi.org\/10.1186\/cc12783.","journal-title":"Crit Care"},{"key":"812_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/mbc.0000000000000572","volume":"28","author":"B Adamik","year":"2017","unstructured":"Adamik B, Gozdzik W, Jakubczyk D, Welna M, K\u00fcbler A. Coagulation abnormalities identified by thromboelastometry in patients with severe sepsis: the relationship to endotoxemia and mortality. Blood Coagul Fibrinolysis. 2017;28:163\u201370. https:\/\/doi.org\/10.1097\/mbc.0000000000000572.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"812_CR12","doi-asserted-by":"publisher","unstructured":"Mori S, Ai T, Sera T, Ochiai K, Otomo Y. Human soluble recombinant thrombomodulin, ART-123, resolved early phase coagulopathies, but did not significantly alter the 28\u00a0day outcome in the treatment of DIC associated with infectious systemic inflammatory response syndromes. J Clin Med. 2019;8. https:\/\/doi.org\/10.3390\/jcm8101553.","DOI":"10.3390\/jcm8101553"},{"key":"812_CR13","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1007\/s00134-016-4405-5","volume":"42","author":"F Pappalardo","year":"2016","unstructured":"Pappalardo F, et al. Protein C Zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study. Intensive Care Med. 2016;42:1706\u201314. https:\/\/doi.org\/10.1007\/s00134-016-4405-5.","journal-title":"Intensive Care Med"},{"key":"812_CR14","doi-asserted-by":"publisher","unstructured":"Gando S, et al. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis. Crit Care. 2013;17. https:\/\/doi.org\/10.1186\/cc13163.","DOI":"10.1186\/cc13163"},{"key":"812_CR15","first-page":"736","volume":"17","author":"YH Ai","year":"2005","unstructured":"Ai YH, et al. Clinical study of low molecular weight heparin therapy for sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi xue = Chin Crit Care Med = Zhongguo Weizhongbing Jijiuyixue. 2005;17:736\u20139.","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi xue = Chin Crit Care Med = Zhongguo Weizhongbing Jijiuyixue"},{"key":"812_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3892\/etm.2013.1466","volume":"7","author":"XL Liu","year":"2014","unstructured":"Liu XL, et al. Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: A prospective clinical study. Experimental Therapeutic Med. 2014;7:604\u20138. https:\/\/doi.org\/10.3892\/etm.2013.1466.","journal-title":"Experimental Therapeutic Med"},{"key":"812_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jama.290.2.238","volume":"290","author":"E Abraham","year":"2003","unstructured":"Abraham E, et al. Efficacy and safety of Tifacogin (Recombinant tissue factor pathway Inhibitor) in severe sepsis: A randomized controlled trial. JAMA. 2003;290:238\u201347. https:\/\/doi.org\/10.1001\/jama.290.2.238.","journal-title":"JAMA"},{"key":"812_CR18","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1097\/TA.0b013e3182516ab5","volume":"72","author":"Y Ogawa","year":"2012","unstructured":"Ogawa Y, et al. Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis. J Trauma Acute Care Surg. 2012;72:1150\u20137. https:\/\/doi.org\/10.1097\/TA.0b013e3182516ab5.","journal-title":"J Trauma Acute Care Surg"},{"key":"812_CR19","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1186\/cc10228","volume":"15","author":"K Yamakawa","year":"2011","unstructured":"Yamakawa K, et al. Treatment effects of Recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study. Crit Care. 2011;15:R123. https:\/\/doi.org\/10.1186\/cc10228.","journal-title":"Crit Care"},{"key":"812_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00134-013-2822-2","volume":"39","author":"K Yamakawa","year":"2013","unstructured":"Yamakawa K, et al. Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Intensive Care Med. 2013;39:644\u201352. https:\/\/doi.org\/10.1007\/s00134-013-2822-2.","journal-title":"Intensive Care Med"},{"key":"812_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1160\/th15-01-0053","volume":"114","author":"T Tagami","year":"2015","unstructured":"Tagami T, Matsui H, Fushimi K, Yasunaga H. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis. Thromb Haemost. 2015;114:537\u201345. https:\/\/doi.org\/10.1160\/th15-01-0053.","journal-title":"Thromb Haemost"},{"key":"812_CR22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1160\/th15-12-0987","volume":"115","author":"M Hayakawa","year":"2016","unstructured":"Hayakawa M, et al. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study. Thromb Haemost. 2016;115:1157\u201366. https:\/\/doi.org\/10.1160\/th15-12-0987.","journal-title":"Thromb Haemost"},{"key":"812_CR23","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/jth.12643","volume":"12","author":"T Tagami","year":"2014","unstructured":"Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost. 2014;12:1470\u20139. https:\/\/doi.org\/10.1111\/jth.12643.","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"812_CR24","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1007\/BF01738945","volume":"19","author":"HP Schuster","year":"1993","unstructured":"Schuster HP. AT III in septicemia with DIC. Intensive Care Med. 1993;19(Suppl 1):S16\u20138. https:\/\/doi.org\/10.1007\/BF01738945.","journal-title":"Intensive Care Med"},{"issue":"4","key":"812_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/jcrc.2001.30666","volume":"16","author":"M Levi","year":"2001","unstructured":"Levi M. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient. J Crit Care. 2001;16(4):167\u201377. https:\/\/doi.org\/10.1053\/jcrc.2001.30666.","journal-title":"J Crit Care"},{"key":"812_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"key":"812_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186.","journal-title":"Stat Med"},{"key":"812_CR28","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","volume":"41","author":"JL Vincent","year":"2013","unstructured":"Vincent JL, et al. A randomized, double-blind, placebo-controlled, phase 2b study to evaluate the safety and efficacy of Recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med. 2013;41:2069\u201379. https:\/\/doi.org\/10.1097\/CCM.0b013e31828e9b03.","journal-title":"Crit Care Med"},{"key":"812_CR29","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, et al. Effect of a Recombinant human soluble thrombomodulin on mortality in patients with Sepsis-Associated coagulopathy: the SCARLET randomized clinical trial. JAMA. 2019;321:1993\u20132002. https:\/\/doi.org\/10.1001\/jama.2019.5358.","journal-title":"JAMA"},{"key":"812_CR30","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","volume":"286","author":"BL Warren","year":"2001","unstructured":"Warren BL, et al. High-dose antithrombin III in severe sepsis: A randomized controlled trial. JAMA. 2001;286:1869\u201378. https:\/\/doi.org\/10.1001\/jama.286.15.1869.","journal-title":"JAMA"},{"key":"812_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard GR, et al. Efficacy and safety of Recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699\u2013709. https:\/\/doi.org\/10.1056\/NEJM200103083441001.","journal-title":"N Engl J Med"},{"key":"812_CR32","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1097\/00003246-200111000-00003","volume":"29","author":"GR Bernard","year":"2001","unstructured":"Bernard GR, et al. Safety and dose relationship of Recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med. 2001;29:2051\u20139. https:\/\/doi.org\/10.1097\/00003246-200111000-00003.","journal-title":"Crit Care Med"},{"key":"812_CR33","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","volume":"366","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, et al. Drotrecogin Alfa (activated) in adults with septic shock. N Engl J Med. 2012;366:2055\u201364. https:\/\/doi.org\/10.1056\/NEJMoa1202290.","journal-title":"N Engl J Med"},{"key":"812_CR34","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1097\/00003246-200111000-00007","volume":"29","author":"E Abraham","year":"2001","unstructured":"Abraham E, et al. Assessment of the safety of Recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med. 2001;29:2081\u20139. https:\/\/doi.org\/10.1097\/00003246-200111000-00007.","journal-title":"Crit Care Med"},{"key":"812_CR35","doi-asserted-by":"publisher","first-page":"e012850","DOI":"10.1136\/bmjopen-2016-012850","volume":"6","author":"A Hagiwara","year":"2016","unstructured":"Hagiwara A, Tanaka N, Uemura T, Matsuda W, Kimura A. Can Recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial. BMJ Open. 2016;6:e012850. https:\/\/doi.org\/10.1136\/bmjopen-2016-012850.","journal-title":"BMJ Open"},{"key":"812_CR36","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1378\/chest.104.3.882","volume":"104","author":"F Fourrier","year":"1993","unstructured":"Fourrier F, et al. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest. 1993;104:882\u20138. https:\/\/doi.org\/10.1378\/chest.104.3.882.","journal-title":"Chest"},{"key":"812_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/00024382-199711000-00003","volume":"8","author":"D Inthorn","year":"1997","unstructured":"Inthorn D, Hoffmann JN, Hartl WH, M\u00fchlbayer D, Jochum M. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction. Shock (Augusta Ga). 1997;8:328\u201334.","journal-title":"Shock (Augusta Ga)"},{"key":"812_CR38","first-page":"678","volume":"103","author":"JT Hsu","year":"2004","unstructured":"Hsu JT, et al. Efficacy of gabexate mesilate on disseminated intravascular coagulation as a complication of infection developing after abdominal surgery. J Formos Med Assoc. 2004;103:678\u201384.","journal-title":"J Formos Med Assoc"},{"key":"812_CR39","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/CCM.0b013e31819c06bc","volume":"37","author":"F Jaimes","year":"2009","unstructured":"Jaimes F, et al. Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit Care Med. 2009;37:1185\u201396. https:\/\/doi.org\/10.1097\/CCM.0b013e31819c06bc.","journal-title":"Crit Care Med"},{"key":"812_CR40","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/jth.13230","volume":"14","author":"Y Umemura","year":"2016","unstructured":"Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2016;14:518\u201330. https:\/\/doi.org\/10.1111\/jth.13230.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"812_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/sj.thj.6200263","volume":"4","author":"SH Slofstra","year":"2003","unstructured":"Slofstra SH, Spek CA, ten Cate H. Disseminated intravascular coagulation. Hematol J. 2003;4(5):295\u2013302. https:\/\/doi.org\/10.1038\/sj.thj.6200263.","journal-title":"Hematol J"},{"key":"812_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40560-016-0149-0","volume":"4","author":"K Okamoto","year":"2016","unstructured":"Okamoto K, Tamura T, Sawatsubashi Y. Sepsis and disseminated intravascular coagulation. J Intensive Care. 2016;4:23. https:\/\/doi.org\/10.1186\/s40560-016-0149-0. Published 2016 Mar 23.","journal-title":"J Intensive Care"},{"issue":"5","key":"812_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s13054-014-0497-x","volume":"18","author":"T Iba","year":"2014","unstructured":"Iba T, Saitoh D, Wada H, Asakura H. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey. Crit Care. 2014;18(5):497. https:\/\/doi.org\/10.1186\/s13054-014-0497-x. Published 2014 Sep 15.","journal-title":"Crit Care"},{"key":"812_CR44","doi-asserted-by":"publisher","first-page":"1566753","DOI":"10.3389\/fmed.2025.1566753","volume":"12","author":"K Suzuki","year":"2025","unstructured":"Suzuki K, Suzuki A, Sumi K, et al., et al. Reevaluating anticoagulation therapy for sepsis-associated disseminated intravascular coagulation based on endothelial glycocalyx shedding quantification: a single-center, retrospective, observational pilot study. Front Med (Lausanne). 2025;12:1566753. https:\/\/doi.org\/10.3389\/fmed.2025.1566753. Published 2025 Jul 16.","journal-title":"Front Med (Lausanne)"},{"key":"812_CR45","doi-asserted-by":"publisher","first-page":"1144229","DOI":"10.3389\/fimmu.2023.1144229","volume":"14","author":"E Maneta","year":"2023","unstructured":"Maneta E, et al. Endothelial dysfunction and immunothrombosis in sepsis. Front Immunol. 2023;14:1144229. https:\/\/doi.org\/10.3389\/fimmu.2023.1144229.","journal-title":"Front Immunol"},{"key":"812_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13:34\u201345. https:\/\/doi.org\/10.1038\/nri3345.","journal-title":"Nat Rev Immunol"},{"key":"812_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005;131:417\u201330. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05753.x.","journal-title":"Br J Haematol"},{"key":"812_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13054-015-0735-x","volume":"19","author":"S Gando","year":"2015","unstructured":"Gando S, Otomo Y. Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock. Crit Care. 2015;19:72. https:\/\/doi.org\/10.1186\/s13054-015-0735-x.","journal-title":"Crit Care"},{"key":"812_CR49","doi-asserted-by":"publisher","unstructured":"Totoki T, Koami H, Makino Y, et al. Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis. Thromb J. 2024;22(1):84. Published 2024 Sep 30. https:\/\/doi.org\/10.1186\/s12959-024-00653-0","DOI":"10.1186\/s12959-024-00653-0"},{"key":"812_CR50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/2052-0492-2-30","volume":"2","author":"Y Eguchi","year":"2014","unstructured":"Eguchi Y, et al. Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation. J Intensive Care. 2014;2:30. https:\/\/doi.org\/10.1186\/2052-0492-2-30.","journal-title":"J Intensive Care"},{"issue":"11","key":"812_CR51","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/jcm8111869","volume":"8","author":"S Murao","year":"2019","unstructured":"Murao S, Yamakawa K. A systematic summary of systematic reviews on anticoagulant therapy in sepsis. J Clin Med. 2019;8(11):1869. https:\/\/doi.org\/10.3390\/jcm8111869. Published 2019 Nov 4.","journal-title":"J Clin Med"},{"issue":"7","key":"812_CR52","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1055\/s-0044-1786754","volume":"50","author":"T Iba","year":"2024","unstructured":"Iba T, Helms J, Totoki T, Levy JH. Heparins May not be the optimal anticoagulants for sepsis and sepsis-Associated disseminated intravascular coagulation. Semin Thromb Hemost. 2024;50(7):1012\u20138. https:\/\/doi.org\/10.1055\/s-0044-1786754.","journal-title":"Semin Thromb Hemost"},{"key":"812_CR53","doi-asserted-by":"publisher","unstructured":"Vidaurre DPH, Mokhtari M, Osborn AK. The interaction between antithrombin and endothelial heparan sulfate mitigates pulmonary thromboinflammation after trauma and hemorrhagic shock. Shock. 2025;63(4):638\u201347. https:\/\/doi.org\/10.1097\/SHK.0000000000002543.","DOI":"10.1097\/SHK.0000000000002543"},{"issue":"19","key":"812_CR54","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","volume":"125","author":"JH Griffin","year":"2015","unstructured":"Griffin JH, Zlokovic BV, Mosnier LO. Activated protein C: biased for translation. Blood. 2015;125(19):2898\u2013907. https:\/\/doi.org\/10.1182\/blood-2015-02-355974.","journal-title":"Blood"},{"issue":"9","key":"812_CR55","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.11406\/rinketsu.65.1125","volume":"65","author":"D Kudo","year":"2024","unstructured":"Kudo D, Kushimoto S. Rinsho Ketsueki. 2024;65(9):1125\u201330. https:\/\/doi.org\/10.11406\/rinketsu.65.1125.","journal-title":"Rinsho Ketsueki"},{"issue":"4 Suppl","key":"812_CR56","doi-asserted-by":"publisher","first-page":"S329","DOI":"10.1097\/01.CCM.0000057912.71499.A5","volume":"31","author":"PF Laterre","year":"2003","unstructured":"Laterre PF, Wittebole X, Dhainaut JF. Anticoagulant therapy in acute lung injury. Crit Care Med. 2003;31(4 Suppl):S329\u201336. https:\/\/doi.org\/10.1097\/01.CCM.0000057912.71499.A5.","journal-title":"Crit Care Med"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-025-00812-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:01:01Z","timestamp":1767794461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-025-00812-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1186\/s12959-025-00812-x","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}